Realization of an Effective Vaccine Against Elephant Endotheliotropic HerpesvirusSandra Binns2022-03-20T23:46:56-06:00
Realization of an Effective Vaccine Against Elephant Endotheliotropic Herpesvirus Baylor College of Medicine
EEHV is the single largest cause of death for captive juvenile Asian elephants in North America and Europe. Furthermore, EEHV-associated deaths have been documented in wild Asian elephants in their natural range countries in both Africa and Asia, adding yet another threat to this endangered species. With IEF support among others, the Ling laboratory in Houston, Texas has spent the last several years developing the tools needed to discover what parts of the EEHV virus might be useful for developing a vaccine that can induce protective immunity for Asian elephants. This project uses those tools to develop and evaluate an anti-EEHV vaccine and the possibility of adapting it for use in African elephants as well.